Characteristics | BMT group (N=31) | PBSCT group (N=8) | CBT group (N=3) | p Value |
Age (years) | ||||
Median | 42 | 40 | 32 | 0.36 |
Range | 15–56 | 21–58 | 3–60 | |
Sex | ||||
Male | 14 (45.1%) | 4 (50%) | 1 (33.3%) | 0.69 |
Female | 17 (54.9%) | 4 (50%) | 2 (66.6%) | |
Median onset of DE (days) | 287 | 474 | 168 | 0.23 |
Range (days) | 67–1216 | 95–1559 | 33–481 | |
Type of DE | ||||
DE <100 days | 4 (12.9%) | 1 (12.5%) | 2 (66.7%) | 0.05* |
DE >100 days | 27 (87.1%) | 7 (87.5%) | 1 (33.3%) | |
Severe DE/Total | 17.9% (12/67) | 38.9% (7/18) | 7.1% (1/14) | 0.06 |
Severe DE | 12 (38.7%) | 7 (87.5%) | 1 (33.3%) | 0.04* |
Mild DE | 19 (61.3%) | 1 (12.5%) | 2 (66.7%) |
↵* statistically significant.
DE, Dry eye; BMT, bone marrow transplantation; CBT, cord blood transplantation; PBSCT, Peripheral blood stem cell transplantation.